Pathology PPM Attempts Public Offering Of Shares

A bigger AmeriPath, Inc. intends to become first publicly traded pathology company

CEO SUMMARY: AmeriPath’s efforts to become a public company make it the most visible management experiment in the pathology world today. Already considered controversial by many pathologists, should AmeriPath successfully pull off its proposed initial public stock offering, it will assume a leadership position in the industry which cannot be ignored. PATHOLOGY MAY SOON have …

Pathology PPM Attempts Public Offering Of Shares Read More »

To access this post, you must purchase The Dark Report.

The Dark Report • 21806 Briarcliff Dr • Spicewood, TX 78669
Phone: 512-264-7103 • Toll Free Number: 800-560-6363
Email: customerservice@darkintelligencegroup.com

Pathology PPM Attempts Public Offering Of Shares

A bigger AmeriPath, Inc. intends to become first publicly traded pathology company

Comments

TABLE OF CONTENTS

Need A Group Membership? Company Discounts are Available!

You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

You have read 0 of 1 of your complimentary articles this month